AbCellera (ABCL) Gains on Multi-Year Research Deal with Moderna (MRNA)
Tweet Send to a Friend
AbCellera (NASDAQ: ABCL) gains 11% in pre-open trade entered into ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
